HTG Molecular Diagnostics (STU:65H) Price-to-Operating-Cash-Flow : (As of Jun. 01, 2024)

View and export this data going back to 2017. Start your Free Trial

What is HTG Molecular Diagnostics Price-to-Operating-Cash-Flow?

As of today (2024-06-01), HTG Molecular Diagnostics's share price is €0.242. HTG Molecular Diagnostics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2023 was €-14.74. Hence, HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:65H's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 18.045
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

HTG Molecular Diagnostics's Cash Flow from Operations per share for the three months ended in Mar. 2023 was €-1.84. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2023 was €-14.74.

HTG Molecular Diagnostics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Price-to-Operating-Cash-Flow Chart

HTG Molecular Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

HTG Molecular Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow falls into.

HTG Molecular Diagnostics Price-to-Operating-Cash-Flow Calculation

HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.242	/	-14.736
	=

HTG Molecular Diagnostics's Share Price of today is €0.242.
HTG Molecular Diagnostics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.74.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

HTG Molecular Diagnostics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

HTG Molecular Diagnostics (STU:65H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (STU:65H) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

HTGMQ:USA

Address

3430 E. Global Loop, Tucson, AZ, USA, 85706

Website

https://www.htgmolecular.com

HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG Molecular Diagnostics (STU:65H) Headlines

No Headlines